Clinical Trial Update: Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating myo-inositol as adjuvant therapy for Polycystic Ovary Syndrome in IVF has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Myo-inositol (myo-inositol)

Snippet

Sponsor: Centre Hospitalier Departemental Vendee | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: TERMINATED